Switch to:
ISIS Pharmaceuticals Inc (NAS:ISIS)
Additional Paid-In Capital
$1,286.7 Mil (As of Sep. 2015)

ISIS Pharmaceuticals Inc's quarterly additional paid-in capital increased from Mar. 2015 ($1,251.9 Mil) to Jun. 2015 ($1,269.5 Mil) and increased from Jun. 2015 ($1,269.5 Mil) to Sep. 2015 ($1,286.7 Mil).

ISIS Pharmaceuticals Inc's annual additional paid-in capital increased from Dec. 2012 ($1,077.2 Mil) to Dec. 2013 ($1,324.8 Mil) but then declined from Dec. 2013 ($1,324.8 Mil) to Dec. 2014 ($1,224.5 Mil).


Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

ISIS Pharmaceuticals Inc Annual Data

AdditionalPaidInCapital 770.3881.0828.0905.7985.61,000.21,013.61,077.21,324.81,224.5

ISIS Pharmaceuticals Inc Quarterly Data

AdditionalPaidInCapital 1,292.71,315.61,324.81,343.91,353.01,365.41,224.51,251.91,269.51,286.7
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership